Phase3 Study of Amrubicin With Cisplatin Versus Etoposide-cisplatin for Extensive Disease Small Cell Lung Cancer
Status:
Completed
Trial end date:
2012-08-01
Target enrollment:
Participant gender:
Summary
This study drug(Amrubicin)is believed to work by stopping the tumor cell in your body from
growing. The purpose of this study is to evaluate the efficacy and safety of amrubicin with
cisplatin compared to etoposide-cisplatin in the first-line treatment in extensive disease
small cell lung cancer The subject, who is randomized to AP group may be involved into a
pharmacokinetic study of amrubicin and the metabolites: amrubicinol voluntarily.